From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 526,999 shares, representing 3.08% for $7.52 million under the buyback announced on March 14, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.12 USD | -1.51% | -7.79% | -22.29% |
Jun. 05 | Transcript : OptimizeRx Corporation - Shareholder/Analyst Call | |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.29% | 203M | |
+27.66% | 443B | |
+31.75% | 276B | |
+12.57% | 145B | |
+7.73% | 93.11B | |
+24.68% | 90.17B | |
+64.02% | 61.13B | |
+14.54% | 46.32B | |
+23.05% | 35.73B | |
-12.79% | 31.13B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023.